Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-γ release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Reward signalling in brainstem nuclei under fluctuating blood glucose

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Experiences managing pregnant hospital staff members using an active management policy-A qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Histological outcomes in HPV-screened elderly women in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The association between conventional risk factors and diabetes is weak among urban Tanzanians

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Andreas V Jensen
  • Lotte Jensen
  • Daniel Faurholt-Jepsen
  • Martine G Aabye
  • George PrayGod
  • Jeremiah Kidola
  • Maria Faurholt-Jepsen
  • John Changalucha
  • Nyagosya Range
  • Henrik Krarup
  • Henrik Friis
  • Aase B Andersen
View graph of relations

INTRODUCTION: One third of the world's population is estimated to be latently infected with Mycobacterium tuberculosis (LTBI). Surveys of LTBI are rarely performed in resource poor TB high endemic countries like Tanzania although low-income countries harbor the largest burden of the worlds LTBI. The primary objective was to estimate the prevalence of LTBI in household contacts of pulmonary TB cases and a group of apparently healthy neighborhood controls in an urban setting of such a country. Secondly we assessed potential impact of LTBI on inflammation by quantitating circulating levels of an acute phase reactant: alpha-1-acid glycoprotein (AGP) in neighborhood controls.

METHODS: The study was nested within the framework of two nutrition studies among TB patients in Mwanza, Tanzania. Household contacts- and neighborhood controls were invited to participate. The study involved a questionnaire, BMI determination and blood samples to measure AGP, HIV testing and a Quantiferon Gold In tube (QFN-IT) test to detect signs of LTBI.

RESULTS: 245 household contacts and 192 neighborhood controls had available QFN-IT data. Among household contacts, the proportion of QFT-IT positive was 59% compared to 41% in the neighborhood controls (p = 0.001). In a linear regression model adjusted for sex, age, CD4 and HIV, a QFT-IT positive test was associated with a 10% higher level of alpha-1-acid glycoprotein(AGP) (10(B) 1.10, 95% CI 1.01; 1.20, p = 0.03), compared to individuals with a QFT-IT negative test.

CONCLUSION: LTBI is highly prevalent among apparently healthy urban Tanzanians even without known exposure to TB in the household. LTBI was found to be associated with elevated levels of AGP. The implications of this observation merit further studies.

Original languageEnglish
JournalP L o S One
Volume8
Issue number5
Pages (from-to)e64008
ISSN1932-6203
DOIs
Publication statusPublished - 2013

    Research areas

  • Adult, Coinfection, Cross-Sectional Studies, Female, HIV Infections, Humans, Interferon-gamma Release Tests, Latent Tuberculosis, Male, Middle Aged, Prevalence, Tanzania, Urban Population, Young Adult, Journal Article, Research Support, Non-U.S. Gov't

ID: 51558813